Myriad Genetics Stock Price and Value Analysis

Should you buy Myriad Genetics stock? (NasdaqGS:MYGN). Let's see how it does in our automated value investing analysis system.

  • This company is making money at a decent rate.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company is less known than others.
  • This company pays no dividend.

MYGN Free Cash Flow Trend

Based on historical returns, we believe that Myriad Genetics can grow its free cash at a rate of about 6%. That's positive!

Free Cash Flow trendline for MYGN
Free Cash Flow trendline for Myriad Genetics

Inside the MYGN Numbers

MYGN Price
(Myriad Genetics stock price per share)
[?] MYGN Fair Price
(based on intrinsic value)
[?] MYGN Safety Price (based on a variable margin of safety) $15.88
[?] PE Ratio versus Sector 14% lower than other Services stocks
[?] PE Ratio versus Industry 40% lower than other Research Services stocks
[?] Cash Yield 6.16%
[?] Free Cash Flow Jitter 37%

Is Myriad Genetics Stock on Sale?

We believe that Myriad Genetics may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Myriad Genetics looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy MYGN Stock?

Does Myriad Genetics have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.